ArticlePloS one2026
Optimizing breast cancer treatment strategies through fractional-order dynamics: A computational modeling approach.
Article in PloS one, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Breast cancer treatment optimization is hindered by heterogeneity, resistance development, and differences among individuals. Most of the existing traditional mathematical models generally do not consider memory effects in biological systems. This may somewhat limit their predictive capability. Therefore, this study develops a fractional-order computational framework to capture tumor dynamics, immune responses, resistance mechanisms, and effects of thermal therapy regarding memory effects concerning their significance to treatment predictions. We considered the values of fractional order parameter ([Formula: see text]) which varied from 0.75 to 1.0 across five treatment protocols, and the analysis also included four patient populations. Efficacy was highest (32.26) with Continuous protocols at [Formula: see text] = 0.75. Specifically-optimized, patient-specific input yielded context-dependent patterns: Younger patients realized the maximum benefit (32.38) with Continuous therapy at [Formula: see text] = 0.80, while compromised patients had an optimum response (32.36) to Adaptive treatment performed at [Formula: see text] = 0.75. For older patients, the better result (31.82) was achieved using Continuous protocols at [Formula: see text] = 0.93. Parameter sensitivity analyses show that immune cytotoxic killing rate is the most effective parameter. In addition, treatment resistance parameters are among the five most sensitive. While aggregate differences between fractional-order and integer-order models remain small, context-specific improvements witnessed in certain patient-protocol combinations were as much as 3.68%. Fractional-order modeling thus creates a framework for investigating memory effects in cancer treatment, while actual clinical validation must establish whether such theoretical improvements indeed create a discernible increase in predictive accuracy in practice.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.